SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DDS-OMS who wrote (3213)8/28/1997 9:00:00 AM
From: Richard Singer   of 3991
 
To all

May I offer another method of stock movement analysis? I call it DA.

As per my recent dream, Vivus finds the low 30's again on the current strength of the smaller-cap market.

On September 8 Vivus breaks through intermediate-term resistance at 32 and sprints quickly to 39 accompanied by a news release of UK approval.

A brief retracement to 35 5/8 is followed by an even stronger surge to 50 in the wake of Q3 earnings release of 38 cents.

At 50, maybe I'll lighten my position, retain the balance for the long haul and divert more of my attention to TRMB.

(The above analysis is offered free of charge)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext